As state policymakers confront the substance use disorder (SUD) epidemic, they require a wide range of data – often found in disparate systems – to understand its impact and craft more effective treatment programs and interventions. This report explores best practices and sources for data gathering and describes how states can help communities access and […]
Author Archive for: jmanz
About Jodi Manz
Jodi Manz joined NASHP in August 2019 as the project director with the Chronic and Vulnerable Populations Team, working on a variety of behavioral health and chronic care policy issues. Previously, she served as Assistant Secretary of Health and Human Resources for Virginia, first under Gov. Terry McAuliffe and then under Gov. Ralph Northam. She has a BA in religious studies and a Masters in social work administration, planning, and public policy, both from Virginia Commonwealth University.
Entries by Jodi Manz
Update: On Jan. 27, 2021, the Office of National Drug Control Policy (ONDCP) notified stakeholders that the earlier announcement from the Department of Health and Human Services (HHS) that physicians will no longer have to obtain a federal waiver to prescribe the opioid use disorder treatment buprenorphine to patients – as described in this blog – will not […]
As drug overdose deaths accelerate during the COVID-19 pandemic, states are working to ensure that a continuum of services, including access to harm reduction programs, remain available to people with substance use disorder (SUD). The National Academy for State Health Policy (NASHP) recently spoke to Louisiana’s Viral Hepatitis Coordinator Emilia Myers and STD/HIV/Hepatitis Program Deputy […]
Despite COVID-19 workarounds, such as telehealth and virtual recovery programs enabled by flexible federal guidelines, more than 40 states have reported increases in drug overdoses during the pandemic, underscoring the importance of keeping state harm reduction programs as accessible as possible. As COVID-19 upends the nation’s health care systems, treatment for substance use disorder (SUD) […]
As drug overdose fatalities continue to rise and incarceration rates remain high nationwide despite recent declines, states are increasingly developing opportunities for incarcerated individuals to access evidence-based opioid use disorder (OUD) treatment in state prison facilities. While the forced abstinence during incarceration can temporarily pause substance use itself, providing comprehensive treatment that includes medications for […]
The National Academy for State Health Policy (NASHP) recently spoke to Robert Hansen, executive director of West Virginia’s Office of Drug Control Policy, to learn how the state is expanding opioid use disorder (OUD) treatment access and capacity through strategic partnerships that support its Substance Use Response Plan’s goals. West Virginia has made expanding access […]
People with substance use disorders (SUD) who are experiencing housing instability or homelessness are particularly at risk during the COVID-19 pandemic, leaving states challenged more than ever to identify effective housing strategies that can simultaneously address the complex treatment needs of people with SUD while also curbing the spread of COVID-19 in congregate settings.
During the COVID-19 pandemic, the opioid epidemic has quietly raged on, requiring states to fight a costly, two-front war. While states have rallied to ensure that opioid use disorder (OUD) treatment remains accessible, organizational and workforce challenges persist and the resources and revenue needed to address them are rapidly changing. Gaps in treatment infrastructure and […]